AIIMS Delhi has conducted India’s first dedicated clinical trial of an advanced brain stent for stroke treatment. The GRASSROOT trial, completed in 2025, evaluated the indigenous Supernova stent across multiple centres. The study proved safety and efficacy, leading to CDSCO approval and strengthening India’s medical device ecosystem.

BulletsIn

•  First India-only clinical trial for a stroke intervention device
•  Trial conducted at AIIMS Delhi with eight centres nationwide
•  Focused on severe large vessel occlusion strokes
•  Tested indigenous Supernova stent by Gravity Medical Technology
•  Reported excellent safety and clinical outcomes
•  Results published in BMJ’s Journal of Neurointerventional Surgery
•  CDSCO approval based solely on Indian clinical data
•  Reduces dependence on foreign trials and imported devices
•  Supports Make in India and Atmanirbhar Bharat goals